The board of directors at Atea Pharmaceuticals has a history of experience in the pharmaceutical industry, with a focus on business development and administration. Members of the board have previously served as chairpersons and board members at various pharmaceutical companies, including Fusion Pharmaceuticals, Jounce Therapeutics, Inc., Adaptimmune, ObsEva SA, and UroGen Pharma. In addition, members of the board have also held various vice president positions at Pfizer, including VP of Commercial Development, VP of Specialty Care Business Unit Business Development, and VP of R&D Business Development. Furthermore, the board has members with educational backgrounds in business administration and management from Nova Southeastern University and veterinary pathology and pathobiology from Iowa State University.
View all